Exogenous IL-12 suppresses experimental autoimmune encephalomyelitis (EAE) by tuning IL-10 and IL-5 levels in an IFN-γ-dependent way

Journal of Neuroimmunology

Volumn 176, Issue 1-2, 2006, Pages 63-75

  Berghmans, Nele ^a   Dillen, Chris ^a   Heremans, Hubertine ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Autoimmune disease; Cytokines; Experimental autoimmune encephalomyelitis; Interferon ; Interleukin 12

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 5; NEUTRALIZING ANTIBODY;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; FEMALE; IMMUNIZATION; LYMPH NODE; MALE; MORBIDITY; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RELAPSE; REMISSION; SPLEEN CELL;

ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-5; LYMPHOCYTE ACTIVATION; MICE; SPINAL CORD; TH1 CELLS; TH2 CELLS;

EID: 33746039702     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2006.04.009     Document Type: Article

References (88)

1. Baker D., O'Neill J.K., Gschmeissner S.E., Wilcox C.E., Butter C., and Turk J.L. Induction of chronic relapsing experimental allergic encephalomyelitis in Biozzi mice. J. Neuroimmunol. 28 (1990) 261-270
2. Becher B., Durell B.G., and Noelle R.J. Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12. J. Clin. Invest. 110 (2002) 493-497
3. Bettelli E., Das M.P., Howard E.D., Weiner H.L., Sobel R.A., and Kuchroo V.K. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J. Immunol. 161 (1998) 3299-3306
4. Billiau A. Interferon-γ: biology and role in pathogenesis. Adv. Immunol. 62 (1996) 61-130
5. Billiau A., Heremans H., Vandekerckhove F., Dijkmans R., Sobis H., Meulepas E., and Carton H. Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-γ. J. Immunol. 140 (1988) 1506-1510
6. Billiau A., Heremans H., and Matthys P. The role of interferon-γ in experimental autoimmune disease. In: Bona C.A., and Revillard J.-P. (Eds). Cytokines and Cytokine Receptors. Physiology and Pathological Disorders (2000), Harwood Academic Publishers 300-315
7. Bright J.J., Musuro B.F., Du C., and Sriram S. Expression of IL-12 in CNS and lymphoid organs of mice with experimental allergic encephalitis. J. Neuroimmunol. 82 (1998) 22-30
8. Brown A.M., and McFarlin D.E. Relapsing experimental allergic encephalomyelitis in the SJL/J mouse. Lab. Invest. 45 (1981) 278-284
9. Chu C.-Q., Wittmer S., and Dalton D.K. Failure to suppress the expansion of the activated CD4 T cell population in interferon γ-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J. Exp. Med. 192 (2000) 123-128
10. Collins P.D., Marleau S., Griffiths-Johnson D.A., Jose P.J., and Williams T.J. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J. Exp. Med. 182 (1995) 1169-1174
11. Constantinescu C.S., Wysocka M., Hilliard B., Ventura E.S., Lavi E., Trinchieri G., and Rostami A. Antibodies against IL-12 prevent superantigen-induced and spontaneous relapses of experimental autoimmune encephalomyelitis. J. Immunol. 161 (1998) 5097-5104
12. Constantinescu C.S., Hilliard B., Ventura E., Wysocka M., Showe L., Lavi E., Fujioka T., Scott P., Trinchieri G., and Rostami A. Modulation of susceptibility and resistance to an autoimmune model of multiple sclerosis in prototypically susceptible and resistant strains by neutralization of interleukin-12 and interleukin-4, respectively. Clin. Immunol. 98 (2001) 23-30
13. Cua D.J., Groux H., Hinton D.R., Stohlman S.A., and Coffman R.L. Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis. J. Exp. Med. 189 (1999) 1005-1010
14. Cua D.J., Sherlock J., Chen Y., Murphy C.A., Joyce B., Seymour B., Lucian L., To W., Kwan S., Churakova T., Zurawski S., Wiekowski M., Lira S.A., Gorman D., Kastelein R.A., and Sedgwick J.D. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421 (2003) 744-748
15. Dalton D.K., Pitts-Meek S., Keshav S., Figari I.S., Bradley A., and Stewart T.A. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259 (1993) 1739-1742
16. Di Rosa F., Francesconi A., Di Virgilio A., Finocchi L., Santilio I., and Barnaba V. Lack of Th2 cytokine increase during spontaneous remission of experimental allergic encephalomyelitis. Eur. J. Immunol. 28 (1998) 3893-3903
17. Dijkmans R., Martens E., Beuken E., Cornette F., Dillen C., Heremans H., Boraschi D., and Billiau A. Murine interferon-γ/interleukin-1 fusion protein used as antigens for the generation of hybridomas producing monoclonal anti-interleukin-1 antibodies. Cytokine 3 (1991) 134-140
18. Duong T.T., Finkelman F.D., and Strejan G.H. Effect of interferon-gamma on myelin basic protein-specific T cell line proliferation in response to antigen-pulsed accessory cells. Cell. Immunol. 145 (1992) 311-323
19. Duong T.T., St. Louis J., Gilbert J.J., Finkelman F.D., and Strejan G.H. Effect of anti-interferon-γ and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse. J. Neuroimmunol. 36 (1992) 105-115
20. Duong T.T., Finkelman F.D., Singh B., and Strejan G.H. Effect of anti-interferon-γ monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strains. J. Neuroimmunol. 53 (1994) 101-107
21. Ferber I.A., Brocke S., Taylor-Edwards C., Ridgway W., Dinisco C., Steinman L., Dalton D., and Fathman C.G. Mice with a disrupted IFN-γ gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156 (1996) 5-7
22. Germann T., Gately M.K., Schoenhaut D.S., Lohoff M., Mattner F., Fischer S., Jin S.C., Schmitt E., and Rude E. Interleukin-12/T cell stimulating factor, a cytokine with multiple effects on T helper type 1 (Th1) but not on Th2 cells. Eur. J. Immunol. 23 (1993) 1762-1770
23. Germann T., Szeliga J., Hess H., Störkel S., Podlaski F.J., Gately M.K., Schmitt E., and Rüde E. Administration of interleukin-12 in combination with type II collagen induces severe arthritis in DBA/1 mice. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 4823-4827
24. Gerosa F., Paganin C., Peritt D., Paiola F., Scupoli M.T., Aste-Amezaga M., Frank I., and Trinchieri G. Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-γ and interleukin-10. J. Exp. Med. 183 (1996) 2559-2569
25. Gran B., Chu N., Zhang G.X., Yu S., Li Y., Chen X.H., Kamoun M., and Rostami A. Early administration of IL-12 suppresses EAE through induction of interferon-gamma. J. Neuroimmunol. 156 (2004) 123-131
26. Gran B., Zhang G.X., Yu S., Li J., Chen X.H., Ventura E.S., Kamoun M., and Rostami A. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination. J. Immunol. 169 (2002) 7104-7110
27. Harrington L.E., Hatton R.D., Mangan P.R., Turner H., Murphy T.L., Murphy K.M., and Weaver C.T. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6 (2005) 1123-1132
28. Heremans H., Dijkmans R., Sobis H., Vandekerckhove F., and Billiau A. Regulation by interferons of the local inflammatory response to bacterial lipopolysaccharide. J. Immunol. 138 (1987) 4175-4179
29. Heremans H., Dillen C., Groenen M., Martens E., and Billiau A. Chronic relapsing experimental autoimmune encephalomyelitis (CREAE) in mice: enhancement by monoclonal antibodies against IFN-γ. Eur. J. Immunol. 26 (1996) 2393-2398
30. Heremans H., Dillen C., Groenen M., Matthys P., and Billiau A. Role of endogenous interleukin-12 (IL-12) in induced and spontaneous relapses of experimental autoimmune encephalomyelitis in mice. Eur. Cytokine Netw. 10 (1999) 171-179
31. Hess H., Gately M.K., Rüde E., Schmitt E., Szeliga J., and Germann T. High doses of interleukin-12 inhibit the development of joint disease in DBA/1mice immunized with type II collagen in complete Freund's adjuvant. Eur. J. Immunol. 26 (1996) 187-191
32. Hong J., Li N., Zhang X., Zheng B., and Zhang J.Z. Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 6449-6454
33. Ichikawa M., Koh C.S., Inoue A., Tsuyusaki J., Yamazaki M., Inaba Y., Sekiguchi Y., Itoh M., Yagita H., and Komiyama A. Anti-IL-12 antibody prevents the development and progression of multiple sclerosis-like relapsing-remitting demyelinating disease in NOD mice induced with myelin oligodendrocyte glycoprotein peptide. J. Neuroimmunol. 102 (2000) 56-66
34. Issazadeh S., Ljungdahl A., Hojeberg B., Mustafa M., and Olsson T. Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: dynamics of mRNA expression for interleukin-10, interleukin-12, cytolysin, tumor necrosis factor α and tumor necrosis factor β. J. Neuroimmunol. 61 (1995) 205-212
35. Issazadeh S., Lorentzen J.C., Mustafa M.I., Hojeberg B., Mussener A., and Olsson T. Cytokines in relapsing experimental autoimmune encephalomyelitis in DA rats: persistent mRNA expression of proinflammatory cytokines and absent expression of interleukin-10 and transforming growth factor-β. J. Neuroimmunol. 69 (1996) 103-115
36. Kawakami N., Odoardi F., Ziemssen T., Bradl M., Ritter T., Neuhaus O., Lassmann H., Wekerle H., and Flugel A. Autoimmune CD4+ T cell memory: lifelong persistence of encephalitogenic T cell clones in healthy immune repertoires. J. Immunol. 175 (2005) 69-81
37. Kelchtermans H., De Klerck B., Mitera T., Van Balen M., Bullens D., Billiau A., Leclercq G., and Matthys P. Defective CD4+CD25+ regulatory T cell functioning in collagen-induced arthritis: an important factor in pathogenesis, counter-regulated by endogenous IFN-gamma. Arthritis Res. Ther. 7 (2005) R402-R415
38. Kohm A.P., Carpentier P.A., Anger H.A., and Miller S.D. Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 169 (2002) 4712-4716
39. Kozlowski P.B., Schuller-Lewis G.B., and Wisniewski H.M. Induction of synchronized relapses in SJL/J mice with chronic relapsing experimental allergic encephalomyelitis. Acta Neuropathol. 74 (1987) 163-168
40. Krakowski M., and Owens T. Interferon-γ confers resistance to experimental allergic encephalomyelitis. Eur. J. Immunol. 26 (1996) 1641-1646
41. Kuroda Y., and Shimamoto Y. Human tumor necrosis factor-alpha augments experimental allergic encephalomyelitis in rats. J. Neuroimmunol. 34 (1991) 159-164
42. Lafaille J.J., Keere F.V., Hsu A.L., Baron J.L., Haas W., Raine C.S., and Tonegawa S. Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J. Exp. Med. 186 (1997) 307-312
43. Lenardo M.J. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 353 (1991) 858-861
44. Leonard J.P., Waldburger K.E., and Goldman S.J. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J. Exp. Med. 181 (1995) 381-386
45. Leonard J.P., Waldburger K.E., and Goldman S.J. Regulation of experimental autoimmune encephalomyelitis by interleukin-12. Ann. N.Y. Acad. Sci. 795 (1996) 216-226
46. Lublin F.D., Knobler R.L., Kalman B., Goldhaber M., Marini J., Perrault M., D'Imperio C., Joseph J., Alkan S.S., and Korngold R. Monoclonal anti-γ interferon antibodies enhance experimental allergic encephalomyelitis. Autoimmunity 16 (1993) 267-274
47. Macatonia S.E., Hosken N.A., Litton M., Vieira P., Hsieh C.S., Culpepper J.A., Wysocka M., Trinchieri G., Murphy K.M., and O'Garra A. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J. Immunol. 154 (1995) 5071-5079
48. Manetti R., Parronchi P., Guidizi M.G., Piccinni M.-P., Maggi E., Trinchieri G., and Romagnani S. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing cells. J. Exp. Med. 177 (1993) 1199-1204
49. Martin R., McFarland H.F., and McFarlin D.E. Immunological aspects of demyelinating diseases. Annu. Rev. Immunol. 10 (1992) 153-187
50. Martin D., Near S.L., Bendele A., and Russell D.A. Inhibition of tumor necrosis factor is protective against neurologic dysfunction after active immunization of Lewis rats with myelin basic protein. Exp. Neurol. 131 (1995) 221-228
51. McGeachy M.J., Stephens L.A., and Anderton S.M. Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system. J. Immunol. 175 (2005) 3025-3032
52. McKnight A.J., Zimmer G.J., Fogelman I., Wolf S.F., and Abbas A.K. Effects of IL-12 on helper T cell-dependent immune responses in vivo. J. Immunol. 152 (1994) 2172-2179
53. Mendel I., Kerlero de Rosbo N., and Ben-Nun A. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Eur. J. Immunol. 25 (1995) 1951-1959
54. Mokhtarian M.F., McFarlin D.E., and Raine C.S. Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice. Nature 309 (1984) 356-358
55. Montero E., Nussbaum G., Kaye J.F., Perez R., Lage A., Ben-Nun A., and Cohen I.R. Regulation of experimental autoimmune encephalomyelitis by CD4+, CD25+ and CD8+ T cells: analysis using depleting antibodies. J. Autoimmun. 23 (2004) 1-7
56. Morris S.C., Madden K.B., Adamovicz J.J., Gause W.C., Hubbard B.R., Gately M.K., and Finkelman F.D. Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. J. Immunol. 152 (1994) 1047-1056
57. O'Hara Jr. R.M., Henderson S.L., and Nagelin A. Prevention of a Th1 disease by a Th1 cytokine: IL-12 and diabetes in NOD mice. Ann. N.Y. Acad. Sci. 795 (1996) 241-249
58. Olsson T. Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol. Rev. 144 (1995) 245-268
59. Oppmann B., Lesley R., Blom B., Timans J.C., Xu Y., Hunte B., Vega F., Yu N., Wang J., Singh K., Zonin F., Vaisberg E., Churakova T., Liu M., Gorman D., Wagner J., Zurawski S., Liu Y., Abrams J.S., Moore K.W., Rennick D., de Waal-Malefyt R., Hannum C., Bazan J.F., and Kastelein R.A. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13 (2000) 715-725
60. Owens T., and Sriram S. The immunology of multiple sclerosis and its animal model, experimental allergic encephalomyelitis. Neurol. Clin. 13 (1995) 51-73
61. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., Wang Y., Hood L., Zhu Z., Tian Q., and Dong C. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6 (2005) 1133-1141
62. Petitto J.M., Streit W.J., Huang Z., Butfiloski E., and Schiffenbauer J. Interleukin-2 gene deletion produces a robust reduction in susceptibility to experimental autoimmune encephalomyelitis in C57BL/6 mice. Neurosci. Lett. 285 (2000) 66-70
63. Refaeli Y., Van Parijs L., London C.A., Tschopp J., and Abbas A.K. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity 8 (1998) 615-623
64. Ruddle N.H., Bergman C.M., McGrath K.M., Lingenheld E.G., Grunnet M.L., Padula S.J., and Clark R.B. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 172 (1990) 1193-1200
65. Segal B.M., and Shevach E.M. IL-12 unmasks latent autoimmune disease in resistant mice. J. Exp. Med. 184 (1996) 771-775
66. Segal B.M., Klinman D.M., and Shevach E.M. Microbial products induce autoimmune disease by an IL-12-dependent pathway. J. Immunol. 158 (1997) 5087-5090
67. Segal B.M., Dwyer B.K., and Shevach E.M. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J. Exp. Med. 187 (1998) 537-546
68. Selmaj K., Raine C.S., and Cross A.H. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann. Neurol. 30 (1991) 694-700
69. Smith T., Hewson A.K., Kingsley C.I., Leonard J.P., and Cuzner M.L. IL-12 induces relapse in experimental allergic encephalomyelitis in the Lewis rat. Am. J. Pathol. 150 (1997) 1909-1917
70. Swain S.L., Weinberg A.D., English M., and Huston G. IL-4 directs the development of Th2-like helper effectors. J. Immunol. 145 (1990) 3796-3806
71. Tanuma N., Kojima T., Shin T., Aikawa Y., Kohji T., Ishihara Y., and Matsumoto Y. Competitive PCR quantification of pro- and anti-inflammatory cytokine mRNA in the central nervous system during autoimmune encephalomyelitis. J. Neuroimmunol. 73 (1997) 197-206
72. Tarrant T.K., Silver P.B., Chan C.-C., Wiggert B., and Caspi R.R. Endogenous IL-12 is required for induction and expression of experimental autoimmune uveitis. J. Immunol. 161 (1998) 122-127
73. Tarrant T.K., Silver P.B., Wahlsten J.L., Rizzo L.V., Chan C.C., Wiggert B., and Caspi R.R. Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon gamma, nitric oxide, and apoptosis. J. Exp. Med. 189 (1999) 219-230
74. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13 (1995) 251-276
75. van der Veen R.C., and Stohlman S.A. Encephalitogenic Th1 cells are inhibited by Th2 cells with related peptide specificity: relative roles of interleukin (IL)-4 and IL-10. J. Neuroimmunol. 48 (1993) 213-220
76. Voorthuis J.A.C., Uitdehaag B.M.J., De Groot C.J.A., Goede P.H., Van der Meide P.H., and Dijkstra C.D. Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon-γ in rats. Clin. Exp. Immunol. 81 (1990) 183-188
77. Waldburger K.E., Hastings R.C., Schaub R.G., Goldman S.J., and Leonard J.P. Adoptive transfer of experimental allergic encephalomyelitis after in vitro treatment with recombinant murine interleukin-12-preferential expansion of interferon-γ-producing cells and increased expression of macrophage-associated inducible nitric oxide synthase as immunomodulatory mechanisms. Am. J. Pathol. 148 (1996) 375-382
78. Weir C., Bernard C.C., and Backstrom B.T. IL-5-deficient mice are susceptible to experimental autoimmune encephalomyelitis. Int. Immunol. 15 (2003) 1283-1289
79. Wensky A., Marcondes M.C., and Lafaille J.J. The role of IFN-gamma in the production of Th2 subpopulations: implications for variable Th2-mediated pathologies in autoimmunity. J. Immunol. 167 (2001) 3074-3081
80. Willenborg D.O., Fordham S., Bernard C.C.A., Cowden W.B., and Ramshaw I.A. IFN-γ plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 157 (1996) 3223-3227
81. Windhagen A., Anderson D.E., Carrizosa A., Williams R.E., and Hafler D.A. IL-12 induces human T cells secreting IL-10 with IFN-γ. J. Immunol. 157 (1996) 1127-1131
82. Wu C.Y., Kirman J.R., Rotte M.J., Davey D.F., Perfetto S.P., Rhee E.G., Freidag B.L., Hill B.J., Douek D.C., and Seder R.A. Distinct lineages of T(H)1 cells have differential capacities for memory cell generation in vivo. Nat. Immunol. 3 (2002) 852-858
83. Xu H., Rizzo L.V., Silver P.B., and Caspi R.R. Uveitogenicity is associated with a Th1-like lymphokine profile: cytokine-dependent modulation of early and committed effector T cells in experimental autoimmune uveitis. Cell. Immunol. 178 (1997) 69-78
84. Yang J., Lindsberg P.J., Hukkanen V., Seljelid R., Gahmberg C.G., and Meri S. Differential expression of cytokines (IL-2, IFN-gamma, IL-10) and adhesion molecules (VCAM-1, LFA-1, CD44) between spleen and lymph nodes associates with remission in chronic relapsing experimental autoimmune encephalomyelitis. Scand. J. Immunol. 56 (2002) 286-293
85. Zaccone P., Hutchings P., Nicoletti F., Penna G., Adorini L., and Cooke A. The involvement of IL-12 in murine experimentally induced autoimmune thyroid disease. Eur. J. Immunol. 29 (1999) 1933-1942
86. Zamvil S.S., and Steinman L. The T lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol. 8 (1990) 579-621
87. Zhang G.X., Gran B., Yu S., Li J., Siglienti I., Chen X., Kamoun M., and Rostami A. Induction of experimental autoimmune encephalomyelitis in IL-12 receptor-beta 2-deficient mice: IL-12 responsiveness is not required in the pathogenesis of inflammatory demyelination in the central nervous system. J. Immunol. 170 (2003) 2153-2160
88. Zhang X., Koldzic D.N., Izikson L., Reddy J., Nazareno R.F., Sakaguchi S., Kuchroo V.K., and Weiner H.L. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells. Int. Immunol. 16 (2004) 249-256